Embryonic Stem Cell Fight Continues

A US district court judge will soon rule on whether federal guidelines on human embryonic stem cell funding incentivize the destruction of embryos.

Written byTia Ghose
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Neurons derived from human embryonic stem cellsRUSSO E., PLOS BIOLOGY VOL. 3/7/2005, E234, WIKIMEDIA COMMONS

The Justice department and two doctors last week (June 24) filed new legal briefs regarding the eligibility of human embryonic stem cell (hESC) research for federal funding, ScienceInsider reports. In their brief, the plaintiffs argue that federal support of hESC research inevitably encourages egg donation and the resultant embryo destruction by increasing the demand for new stem cell lines. The Justice department countered that the plaintiffs’ argument is irrelevant, as the debate is about the funding of research on already derived hESC lines, which does not subject embryos to any harm.

The briefs are the latest in an ongoing legal battle over hESC funding, spurred by President Obama’s 2009 decision to allow federal support for such research. In October 2009, James Sherley, a researcher at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies